Format

Send to

Choose Destination
Respir Med. 2019 Aug;155:49-50. doi: 10.1016/j.rmed.2019.07.003. Epub 2019 Jul 3.

Adverse cardiac outcomes after pulmonary function testing with recent myocardial infarction.

Author information

1
The Department of Thoracic Medicine, The Royal Adelaide Hospital, Port Rd, Adelaide, South Australia, 5000, Australia. Electronic address: tom.altree@sydney.edu.au.
2
The Department of Thoracic Medicine, The Royal Adelaide Hospital, Port Rd, Adelaide, South Australia, 5000, Australia. Electronic address: lauren.bussell@adelaide.edu.au.
3
The Department of Thoracic Medicine, The Royal Adelaide Hospital, Port Rd, Adelaide, South Australia, 5000, Australia; The University of Adelaide Faculty of Health and Medical Sciences, Level 3, Helen Mayo North, Frome Road, North Terrace, Adelaide, South Australia, 5000, Australia. Electronic address: phantien.nguyen@adelaide.edu.au.
4
The Department of Thoracic Medicine, The Royal Adelaide Hospital, Port Rd, Adelaide, South Australia, 5000, Australia. Electronic address: sonya.johnston@adelaide.edu.au.

Abstract

ATS/ERS Guidelines list pulmonary function testing (PFT) within one month of myocardial infarction (MI) as a contraindication, based on expert opinion. This retrospective review of 136 patients undergoing Coronary Artery Bypass Graft (CABG) surgery identified 21 patients who had PFTs despite MI in the preceding month (MI + PFT group). The MI + PFT Group had zero incidence of MI or serious cardiac arrhythmia between PFTs and surgery. Comparison of post-operative outcomes between the MI + PFT Group and all other CABG patients showed no significant differences. In this small sample size, PFTs appear safe within one month of MI.

KEYWORDS:

Chronic obstructive pulmonary disease; Pre-operative assessment; Pulmonary function testing; Spirometry

PMID:
31299467
DOI:
10.1016/j.rmed.2019.07.003

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center